Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
Identifieur interne : 003853 ( PubMed/Curation ); précédent : 003852; suivant : 003854Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
Auteurs : Samuel Shapiro ; Tobie J. Devilliers ; Amos Pines ; David W. Sturdee ; David F. Archer ; Rod J. Baber ; Nick Panay ; Richard D T. Farmer ; John C. Stevenson ; Alfred O. Mueck ; Henry G. Burger ; Anne GompelSource :
- Journal of the National Cancer Institute [ 1460-2105 ] ; 2014.
Descripteurs français
- KwdFr :
- Carcinome canalaire du sein (), Carcinome canalaire du sein (épidémiologie), Femelle, Humains, Oestrogènes (effets indésirables), Oestrogénothérapie substitutive (), Oestrogénothérapie substitutive (effets indésirables), Progestines (effets indésirables), Tumeurs du sein (), Tumeurs du sein (épidémiologie).
- MESH :
- effets indésirables : Oestrogènes, Oestrogénothérapie substitutive, Progestines.
- épidémiologie : Carcinome canalaire du sein, Tumeurs du sein.
- Carcinome canalaire du sein, Femelle, Humains, Oestrogénothérapie substitutive, Tumeurs du sein.
English descriptors
- KwdEn :
- Breast Neoplasms (chemically induced), Breast Neoplasms (epidemiology), Carcinoma, Ductal, Breast (chemically induced), Carcinoma, Ductal, Breast (epidemiology), Estrogen Replacement Therapy (adverse effects), Estrogen Replacement Therapy (methods), Estrogens (adverse effects), Female, Humans, Progestins (adverse effects).
- MESH :
- chemical , adverse effects : Estrogens, Progestins.
- adverse effects : Estrogen Replacement Therapy.
- chemically induced : Breast Neoplasms, Carcinoma, Ductal, Breast.
- epidemiology : Breast Neoplasms, Carcinoma, Ductal, Breast.
- methods : Estrogen Replacement Therapy.
- Female, Humans.
DOI: 10.1093/jnci/djt372
PubMed: 24363446
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003968
Links to Exploration step
pubmed:24363446Curation
No country items
Samuel Shapiro<affiliation><nlm:affiliation>Affiliations of authors: Department of Public Health and Family Medicine, University of Capetown, Cape Town, South Africa (SS); Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town, South Africa (TJD); Department of Medicine, Tel Aviv University, Tel Aviv, Israel (AP); Department of Obstetrics and Gynecology, Solihull Hospital, Solihull, UK (DWS); Department of Obstetrics and Gynecology, East Virginia Medical School, Norfolk, VA (DFA); Department of Obstetrics and Gynecology, University of Sydney, St. Leonards, Australia (RJB); Department of Obstetrics and Gynecology, Queen Charlotte's and Chelsea and Westminster Hospitals (NP), National Heart and Lung Institute (JCS), Imperial College, London, UK; Women's Hospital, University of Tubingen, Tubingen, Germany (AOM); Departments of Endocrinology and Medicine, Prince Henry's Institute, Melbourne, Australia (HB); Department of Gynecology, University Paris Descartes, Paris, France (AG).</nlm:affiliation><wicri:noCountry code="subField">France (AG)</wicri:noCountry></affiliation>Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.</title><author><name sortKey="Shapiro, Samuel" sort="Shapiro, Samuel" uniqKey="Shapiro S" first="Samuel" last="Shapiro">Samuel Shapiro</name><affiliation><nlm:affiliation>Affiliations of authors: Department of Public Health and Family Medicine, University of Capetown, Cape Town, South Africa (SS); Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town, South Africa (TJD); Department of Medicine, Tel Aviv University, Tel Aviv, Israel (AP); Department of Obstetrics and Gynecology, Solihull Hospital, Solihull, UK (DWS); Department of Obstetrics and Gynecology, East Virginia Medical School, Norfolk, VA (DFA); Department of Obstetrics and Gynecology, University of Sydney, St. Leonards, Australia (RJB); Department of Obstetrics and Gynecology, Queen Charlotte's and Chelsea and Westminster Hospitals (NP), National Heart and Lung Institute (JCS), Imperial College, London, UK; Women's Hospital, University of Tubingen, Tubingen, Germany (AOM); Departments of Endocrinology and Medicine, Prince Henry's Institute, Melbourne, Australia (HB); Department of Gynecology, University Paris Descartes, Paris, France (AG).</nlm:affiliation><wicri:noCountry code="subField">France (AG)</wicri:noCountry></affiliation></author><author><name sortKey="Devilliers, Tobie J" sort="Devilliers, Tobie J" uniqKey="Devilliers T" first="Tobie J" last="Devilliers">Tobie J. Devilliers</name></author><author><name sortKey="Pines, Amos" sort="Pines, Amos" uniqKey="Pines A" first="Amos" last="Pines">Amos Pines</name></author><author><name sortKey="Sturdee, David W" sort="Sturdee, David W" uniqKey="Sturdee D" first="David W" last="Sturdee">David W. Sturdee</name></author><author><name sortKey="Archer, David F" sort="Archer, David F" uniqKey="Archer D" first="David F" last="Archer">David F. Archer</name></author><author><name sortKey="Baber, Rod J" sort="Baber, Rod J" uniqKey="Baber R" first="Rod J" last="Baber">Rod J. Baber</name></author><author><name sortKey="Panay, Nick" sort="Panay, Nick" uniqKey="Panay N" first="Nick" last="Panay">Nick Panay</name></author><author><name sortKey="Farmer, Richard D T" sort="Farmer, Richard D T" uniqKey="Farmer R" first="Richard D T" last="Farmer">Richard D T. Farmer</name></author><author><name sortKey="Stevenson, John C" sort="Stevenson, John C" uniqKey="Stevenson J" first="John C" last="Stevenson">John C. Stevenson</name></author><author><name sortKey="Mueck, Alfred O" sort="Mueck, Alfred O" uniqKey="Mueck A" first="Alfred O" last="Mueck">Alfred O. Mueck</name></author><author><name sortKey="Burger, Henry G" sort="Burger, Henry G" uniqKey="Burger H" first="Henry G" last="Burger">Henry G. Burger</name></author><author><name sortKey="Gompel, Anne" sort="Gompel, Anne" uniqKey="Gompel A" first="Anne" last="Gompel">Anne Gompel</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24363446</idno><idno type="pmid">24363446</idno><idno type="doi">10.1093/jnci/djt372</idno><idno type="wicri:Area/PubMed/Corpus">003968</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003968</idno><idno type="wicri:Area/PubMed/Curation">003853</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003853</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.</title><author><name sortKey="Shapiro, Samuel" sort="Shapiro, Samuel" uniqKey="Shapiro S" first="Samuel" last="Shapiro">Samuel Shapiro</name><affiliation><nlm:affiliation>Affiliations of authors: Department of Public Health and Family Medicine, University of Capetown, Cape Town, South Africa (SS); Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town, South Africa (TJD); Department of Medicine, Tel Aviv University, Tel Aviv, Israel (AP); Department of Obstetrics and Gynecology, Solihull Hospital, Solihull, UK (DWS); Department of Obstetrics and Gynecology, East Virginia Medical School, Norfolk, VA (DFA); Department of Obstetrics and Gynecology, University of Sydney, St. Leonards, Australia (RJB); Department of Obstetrics and Gynecology, Queen Charlotte's and Chelsea and Westminster Hospitals (NP), National Heart and Lung Institute (JCS), Imperial College, London, UK; Women's Hospital, University of Tubingen, Tubingen, Germany (AOM); Departments of Endocrinology and Medicine, Prince Henry's Institute, Melbourne, Australia (HB); Department of Gynecology, University Paris Descartes, Paris, France (AG).</nlm:affiliation><wicri:noCountry code="subField">France (AG)</wicri:noCountry></affiliation></author><author><name sortKey="Devilliers, Tobie J" sort="Devilliers, Tobie J" uniqKey="Devilliers T" first="Tobie J" last="Devilliers">Tobie J. Devilliers</name></author><author><name sortKey="Pines, Amos" sort="Pines, Amos" uniqKey="Pines A" first="Amos" last="Pines">Amos Pines</name></author><author><name sortKey="Sturdee, David W" sort="Sturdee, David W" uniqKey="Sturdee D" first="David W" last="Sturdee">David W. Sturdee</name></author><author><name sortKey="Archer, David F" sort="Archer, David F" uniqKey="Archer D" first="David F" last="Archer">David F. Archer</name></author><author><name sortKey="Baber, Rod J" sort="Baber, Rod J" uniqKey="Baber R" first="Rod J" last="Baber">Rod J. Baber</name></author><author><name sortKey="Panay, Nick" sort="Panay, Nick" uniqKey="Panay N" first="Nick" last="Panay">Nick Panay</name></author><author><name sortKey="Farmer, Richard D T" sort="Farmer, Richard D T" uniqKey="Farmer R" first="Richard D T" last="Farmer">Richard D T. Farmer</name></author><author><name sortKey="Stevenson, John C" sort="Stevenson, John C" uniqKey="Stevenson J" first="John C" last="Stevenson">John C. Stevenson</name></author><author><name sortKey="Mueck, Alfred O" sort="Mueck, Alfred O" uniqKey="Mueck A" first="Alfred O" last="Mueck">Alfred O. Mueck</name></author><author><name sortKey="Burger, Henry G" sort="Burger, Henry G" uniqKey="Burger H" first="Henry G" last="Burger">Henry G. Burger</name></author><author><name sortKey="Gompel, Anne" sort="Gompel, Anne" uniqKey="Gompel A" first="Anne" last="Gompel">Anne Gompel</name></author></analytic><series><title level="j">Journal of the National Cancer Institute</title><idno type="eISSN">1460-2105</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (chemically induced)</term><term>Breast Neoplasms (epidemiology)</term><term>Carcinoma, Ductal, Breast (chemically induced)</term><term>Carcinoma, Ductal, Breast (epidemiology)</term><term>Estrogen Replacement Therapy (adverse effects)</term><term>Estrogen Replacement Therapy (methods)</term><term>Estrogens (adverse effects)</term><term>Female</term><term>Humans</term><term>Progestins (adverse effects)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Carcinome canalaire du sein ()</term><term>Carcinome canalaire du sein (épidémiologie)</term><term>Femelle</term><term>Humains</term><term>Oestrogènes (effets indésirables)</term><term>Oestrogénothérapie substitutive ()</term><term>Oestrogénothérapie substitutive (effets indésirables)</term><term>Progestines (effets indésirables)</term><term>Tumeurs du sein ()</term><term>Tumeurs du sein (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Estrogens</term><term>Progestins</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Estrogen Replacement Therapy</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Ductal, Breast</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Oestrogènes</term><term>Oestrogénothérapie substitutive</term><term>Progestines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Ductal, Breast</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Estrogen Replacement Therapy</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Carcinome canalaire du sein</term><term>Tumeurs du sein</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Carcinome canalaire du sein</term><term>Femelle</term><term>Humains</term><term>Oestrogénothérapie substitutive</term><term>Tumeurs du sein</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24363446</PMID><DateCreated><Year>2014</Year><Month>01</Month><Day>31</Day></DateCreated><DateCompleted><Year>2014</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2014</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1460-2105</ISSN><JournalIssue CitedMedium="Internet"><Volume>106</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the National Cancer Institute</Title><ISOAbbreviation>J. Natl. Cancer Inst.</ISOAbbreviation></Journal><ArticleTitle>Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.</ArticleTitle><Pagination><MedlinePgn>djt372</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jnci/djt372</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shapiro</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Affiliations of authors: Department of Public Health and Family Medicine, University of Capetown, Cape Town, South Africa (SS); Department of Obstetrics and Gynecology, Stellenbosch University, Cape Town, South Africa (TJD); Department of Medicine, Tel Aviv University, Tel Aviv, Israel (AP); Department of Obstetrics and Gynecology, Solihull Hospital, Solihull, UK (DWS); Department of Obstetrics and Gynecology, East Virginia Medical School, Norfolk, VA (DFA); Department of Obstetrics and Gynecology, University of Sydney, St. Leonards, Australia (RJB); Department of Obstetrics and Gynecology, Queen Charlotte's and Chelsea and Westminster Hospitals (NP), National Heart and Lung Institute (JCS), Imperial College, London, UK; Women's Hospital, University of Tubingen, Tubingen, Germany (AOM); Departments of Endocrinology and Medicine, Prince Henry's Institute, Melbourne, Australia (HB); Department of Gynecology, University Paris Descartes, Paris, France (AG).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>deVilliers</LastName><ForeName>Tobie J</ForeName><Initials>TJ</Initials></Author><Author ValidYN="Y"><LastName>Pines</LastName><ForeName>Amos</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sturdee</LastName><ForeName>David W</ForeName><Initials>DW</Initials></Author><Author ValidYN="Y"><LastName>Archer</LastName><ForeName>David F</ForeName><Initials>DF</Initials></Author><Author ValidYN="Y"><LastName>Baber</LastName><ForeName>Rod J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Panay</LastName><ForeName>Nick</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Farmer</LastName><ForeName>Richard D T</ForeName><Initials>RD</Initials></Author><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>John C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Mueck</LastName><ForeName>Alfred O</ForeName><Initials>AO</Initials></Author><Author ValidYN="Y"><LastName>Burger</LastName><ForeName>Henry G</ForeName><Initials>HG</Initials></Author><Author ValidYN="Y"><LastName>Gompel</LastName><ForeName>Anne</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Natl Cancer Inst</MedlineTA><NlmUniqueID>7503089</NlmUniqueID><ISSNLinking>0027-8874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004967">Estrogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011372">Progestins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>J Natl Cancer Inst. 2013 Apr 17;105(8):526-35</RefSource><PMID Version="1">23543779</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018270" MajorTopicYN="N">Carcinoma, Ductal, Breast</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015914" MajorTopicYN="N">Estrogen Replacement Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004967" MajorTopicYN="N">Estrogens</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011372" MajorTopicYN="N">Progestins</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24363446</ArticleId><ArticleId IdType="pii">djt372</ArticleId><ArticleId IdType="doi">10.1093/jnci/djt372</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003853 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003853 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24363446
|texte= Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24363446" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |